a b s t r a c t AIMP2-DX2 is a splicing variant of AIMP2 protein which has been implicated in human lung cancer and chemoresistance of ovarian cancer (J.
Specifications

Value of the data
The data includes a process for screening the expression system and optimizing the purification steps for human AIMP2-DX2 protein. This data provides an efficient method to get a high yield of AIMP2-DX2 protein.
The data on SUMO-tag cleavage shows that the protease activity of SUMO-proteases is efficient even at a salt concentration of 500 mM NaCl.
The data on screening the optimal condition for protein purification and stabilization shows that EDTA can be a good additive to prevent aggregation of protein by chelating residual nickel and other metallic impurities from Nickel affinity chromatography. Fig. 1 shows the SDS-PAGE image of the expression and the solubility trial of the AIMP2-DX2 protein with a SUMO-tag in various E. coli cell lines. The E. coli cells were expressed at 37°C and 18°C with 1 mM IPTG. These cells were harvested, lysed and separated as pellet and supernatant before subjecting to SDS-PAGE. The variation in the solubility of SUMO-DX2 at different temperature and cell lines is easily comparable with relative protein band intensity. Fig. 2 shows the SDS-PAGE image comparing the improvement in the stability of the SUMO-tagged AIMP2-DX2 between the optimized and unoptimized buffer conditions. The protective effect of 500 mM NaCl and 10 mM EDTA has been shown here for two critical processes, dialysis and SUMOtag cleavage, during the purification of AIMP2-DX2.
Data
Experimental design, materials and methods
Cloning and expression of protein
Full length human AIMP2 isoform C (hereafter referred as AIMP2-DX2 or DX2) protein was amplified from a PGEX-4T-1 plasmid containing human DX2, reported previously by Choi and Lee et al. [1, 2] . The splicing variant of AIMP2 (NCBI nucleotide accession number NM_006303 and Genbank code U24169) lacking exon2 was generated as described by Choi et al. [1] . To get a high yield of soluble DX2 protein, we designed a cloning strategy to express DX2 with a SUMO protein tag. For this purpose, the yeast SUMO protein (Smt3; Genbank ID BK006938) was cloned into the pET-28a plasmid (Novagen, Germany) between Nhe I and BamH I restriction sites with procedures similar to that reported by Malakhov et al. [4] . Next, the amplified DX2 gene fragment was inserted into this modified pET-28a-SUMO plasmid between restriction sites BamH I and Xho I. The Taq DNA polymerase and all the RE enzymes used were obtained from Enzynomics (South Korea). Standard cloning procedures were followed and the success of the cloning strategy was assessed by DNA sequencing.
The plasmid construct, thus obtained, would express the DX2 protein with a hexahistidine tag followed by a SUMO tag at its N-terminal (for convenience designated as 6His-SUMO-DX2 protein). For screening the best expression system, the 6His-SUMO-DX2 plasmid construct was transformed into four E. coli cell lines, namely, BL21(DE3) (Novagen, Germany), BL21-CodonPlus(DE3)-RIL (Stratagene, USA) and BL21-CodonPlus(DE3)-RIPL (Stratagene, USA). All the E. coli cells were expressed at temperatures 37°C and 18°C with 1 mM IPTG. The expression and the solubility of the 6His-SUMO-DX2 protein were analyzed by SDS-PAGE and the relative band intensity was compared to determine the best E. coli expression system.
Optimization of purification process
DX2 expressed in Escherichia coli BL21-CodonPlus(DE3)-RIPL (Stratagene, USA) at 18°C was cultured, harvested and then lysed by ultrasonication. To purify DX2, this lysate was subjected to nickel affinity chromatography followed by dialysis, tag cleavage and second nickel affinity chromatography. Size exclusion chromatography was used to further separate the oligomer fraction of AIMP2-DX2 (see reference [1] for details). During the dialysis of the elution fraction from nickel affinity chromatography to standard buffer for SUMO-tag cleavage (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM DTT) and the subsequent tag cleavage, precipitation of SUMO-DX2 was severe with loss of about 50-60% of protein. To optimize this step of purification, 500 ml of buffers with several different additives were prepared. Then, the stability of 1-2 ml of elution fractions on dialyzing to these buffers and subsequent tag cleavage was analyzed with SDS-PAGE. Osmolytes (glycerol, mannitol, betaine and trehalose), the salts of the Hofmeister series (MgSO 4 , MgCl 2 , Na 2 SO 4 , NaCl and KCl) and other common additives like EDTA, DTT and mild detergents were checked for their protective action [5, 6] . From the initial screening process, NaCl and EDTA showed the most protective effect. Both NaCl and EDTA were further screened for their protective effect at various concentrations. After several rounds of screening, the most optimal method was to mix the elution fractions from nickel affinity chromatography with EDTA at concentration of 10 mM before extensive dialysis to buffer solution 50 mM Tris-HCl pH 7.4, 1 mM DTT and 500 mM NaCl. This buffer condition was also most suitable for SUMOtag cleavage. It should be noted that the absence of the EDTA in the buffer during tag cleavage had no effect on the stability of the protein.
These data has been successfully used to get a maximum yield (10 mg/L) of highly pure ( 4 95%) AIMP2-DX2 for subsequent characterization of its biophysical property in: "Purification and biophysical characterization of the AIMP2-DX2 protein" (R. Jha, H.Y. Cho, A. Ul Mushtaq, K. Lee, D.G. Kim, S. Kim, et al., 2017) [3] .
